✦ LIBER ✦

Somatic gene therapy for phenylketonuria and other hepatic deficiencies

✍ Scribed by R. C. Eisensmith; S. L. C. Woo

Book ID: 105312267
Publisher: Springer
Year: 1996
Tongue: English
Weight: 951 KB
Volume: 19
Category: Article
ISSN: 0141-8955
DOI: 10.1007/bf01799102

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

FDA rules for somatic-cell and gene ther

FDA rules for somatic-cell and gene therapy

✍ Fox, Jeffrey L. 📂 Article 📅 1993 🏛 Nature Publishing Group 🌐 English ⚖ 122 KB

Prospects for the treatment of phenylket

Prospects for the treatment of phenylketonuria by gene therapy

✍ Eisensmith, Randy C. ;Kuzmin, Alexei I. ;Krougliak, Valeri A. 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB 👁 2 views

Gene therapy is being explored as a means of treating a variety of genetic diseases. Because of the central role of the liver in many metabolic pathways, and the relative ease with which foreign genes can be delivered to hepatocytes, monogenic disorders that result in deficiencies of liver-specific

Glucose- and Metabolically Regulated Hep

Glucose- and Metabolically Regulated Hepatic Insulin Gene Therapy for Diabetes

✍ Paul Yueh-Jen Hsu; Robert M. Kotin; Ya-Wun Yang 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 306 KB

Gene gun and other non-viral approaches

Gene gun and other non-viral approaches for cancer gene therapy

✍ Yang, Ning-Sun; Sun, Wenn H. 📂 Article 📅 1995 🏛 Nature Publishing Group 🌐 English ⚖ 393 KB

Guidelines for the design and implementa

Guidelines for the design and implementation of clinical studies in somatic cell therapy and gene therapy

✍ A. Lindemann; F. M. Rosenthal; R. Mertelsmann; S. Hase; P. Markmeyer 📂 Article 📅 1995 🏛 Springer 🌐 English ⚖ 443 KB

According to Sects. 2 and 3 of the German drug statute, (Arzneimittelgesetz, AMG) gene technology and gene therapy products as well as somatic cell therapy products are regarded as drugs and are therefore subject to Sects. 40 and 41, stipulating the requirements for clinical studies designed to test

Gene therapy for hepatic fibrosis—bringi

Gene therapy for hepatic fibrosis—bringing treatment into the new millennium

✍ Don C. Rockey 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 39 KB

We eliminated type beta transforming growth factor (TGF-beta) signaling by adenovirus-mediated local expression of a dominant-negative type II TGF-beta receptor (AdCATbeta-TR) in the liver of rats treated with dimethylnitrosamine, a model of persistent liver fibrosis. In rats that received a single